期刊文献+

重组人白介素21的原核表达与体外活性研究的优化 被引量:1

Optimization on Expression of Recombinant Human Interleukin 21 and Its Biological Activity Analysis In Vitro
原文传递
导出
摘要 为了构建重组人白介素21(rhIL-21)原核稳定表达和体外活性检测系统,采用Overlap-PCR法合成目的基因;经双酶切整合至pET28,化学转化法转入大肠杆菌BL21(DE3)构建pET-28a-rhIL-21 BL21(DE3)原核表达系统;胞内表达的包涵体经镍亲和层析色谱柱纯化后,尿素缓冲液梯度透析复性,最终溶于PBS缓冲液;双抗体夹心法ELISA、Western blotting检测复性蛋白的生物活性;细胞增殖抑制试验(MTT法)研究rhIL-21对Jurkat细胞株和HuT102细胞株的作用。实验成功建立了rhIL-21表达纯化与活性评价体系,为进一步研究IL-21的促免疫性疾病发展和抗肿瘤活性奠定了基础。 Interleukin-21 is the most recently discovered member of the type-I cytokine family.Structurally,IL-21 shows homology to IL-2,IL-4,and IL-15 proteins.IL-21 shares the common g-chain with the other three cytokines,in addition,binds to a unique IL21Ra chain,and activates the JAK / STAT pathway.IL-21 is mainly produced by activated T-cells but targets a broad range of lymphoid and myeloid cells of the immune system and therefore is able to regulate the innate and acquired immune responses.However,the studies of this cytokine have so far been hampered by the limited availability of recombinant protein preparations.This study established a system of prokaryotic expression of recombinant human interleukin-21(rhIL-21) and identified its biological activity in vitro.rhIL-21 cDNA was obtained using overlap-PCR and inserted into pET28 vector by double restriction endonuclease digesting,finally transformed into E.coli BL21(DE3) by chemical transformation to construct the pET-28a-rhIL-21 BL21(DE3) prokaryotic expression bacteria.The intracellular inclusion body was purified by nickel affinity chromatography,followed with the stage of refolding with gradient decreasing urea buffer.At last rhIL-21 was stored in PBS buffer.The biological activity of rhIL-21 was detected by double antibody enzyme linked immunosorbent assay and western blot.At the same time,the effects of rhIL-21 on Jurkat cell line and HuT102 cell line were studied by MTT method.This experiment successfully established the system of prokaryotic expression and exclaimed the biological function in vitro,which could benefit on the investigation of IL-21 in immune-diseases and cancers.The yield of rhIL-21 protein was 2.26 μg per liter medium after purification by one-step affinity chromatography and refolding.The rhIL-21 on Jurkat cell for 72h after stimulation by 0.5 μg / mL PHA and rhIL-21 on HuT102 cell for 24 h and 48 h showed that the effects of rhIL-21 on Jurkat cell and HuT102 cell were mainly stimulative.This study demonstrated that the rhIL-21 had good biological activity after refolding and could be applied for further immunology research.
出处 《药物生物技术》 CAS 2013年第4期283-287,共5页 Pharmaceutical Biotechnology
基金 江苏省青蓝工程培养计划项目(2010)
关键词 重组人白介素21 Overlap-PCR 原核表达 亲和层析 复性 细胞增殖抑制 Recombinant human interleukin 21 Overlap-PCR Prokaryotic expression Affinity chromatography Renaturation Cell prolifation inhibition
  • 相关文献

参考文献15

  • 1Yi JS, Du M, Zajac AJ. A Vital Role For IL-21 in the Control of a Chronic Viral Infection [ J ]. Science,2009,324 (5934) : 1572.
  • 2Sarra M,Cupi ML,Pallone F,et al. Interleukin-21 in immune and allergic diseases [ J ]. Inflamm Allergy Drug Targets, 2012,11 (4) :313.
  • 3Coquet JM,Kyparissoudis K,Pellicci DG,et al. IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production [ J ]. J lmmunol,2007 ,178 ( 5 ) :2827.
  • 4Brandt K, Singh PB, Bulfone-Paus S, et al. Interleukin-21 : A new modulator of immunity,infection, and cancer [ J ]. Cytokine Growth Factor Rev,2007,18(3-4) :223.
  • 5于杰淼,曹鹏,卢悟广,蔡雪婷,张娟,王旻.SUMO-BMP7融合蛋白的表达及纯化[J].药物生物技术,2009,16(3):189-193. 被引量:8
  • 6李振国,徐明波,牛罡,陈遥,姚文兵.在大肠杆菌周质表达重组蛋白的研究进展[J].药物生物技术,2011,18(1):73-76. 被引量:9
  • 7Chen Z,Cui Y,Leong YA,et al. Efficient production of recombi- nant IL-21 proteins for pre-clinical studies by a two-step dilution refolding method [ J ]. lnt lmmunopharmacol, 2013, 5769 (13) :59.
  • 8Young L, Dong QH. Two-step total gene synthesis method [ J ]. Nucleic Acids Research, 2004,32 ( 7 ) :59.
  • 9Lee CM, McGuire H, Basten A, et al. Expression, purification and characterization of recombinant interleukin-21 [ J ]. J lmmunol Meth ,2010 ,362 (1-2 ) :185.
  • 10Tsumoto K, Ejima D, Kumagai I, et al. Practical considerations in refolding proteins from inclusion bodies [ J ]. Protein Expr Purif, 2003,28( 1 ) : 1.

二级参考文献36

  • 1刘景晶,李晶,吴梧桐,胡梅清.大肠杆菌L-天门冬酰胺酶Ⅱ基因的高效表达[J].中国药科大学学报,1996,27(11):696-700. 被引量:19
  • 2Johnson E S, Blobel G. Cell cycle-regulated attachment of the ubiquitin-related protein SUMO to the yeast septins[J]. J Cell Biol, 1999. 147(5):981.
  • 3Lamsoul I, Lodewiek J, Lebrun S, et al. Exclusive ubiquitination and sumoylation on overlapping lysine residues mediate NF-kappaB activation by the human T-cell leukemia virus tax oncoprotein[J]. Mol Cell Biol, 2005, 25(23) : 10391.
  • 4Ohshima T, Shimotohno K. Transforming growth factor-beta-mediated signaling via the p38 MAP kinase pathway activates Smad-dependent transcription through SUMO - 1 modification of Smad4[J]. J Biol Chem, 2003, 278(51) : 50 833.
  • 5Wood L D, Irvin B J, Nucifora G, et al. Small ubiquitin-like modifier conjugation regulates nuclear export of TEL, a putative tumor suppressor[J]. Proc Natl Acad Sci U S A, 2003, 100(6) :3 257.
  • 6Bayer P, Arndt A, Metzger S, et al. Structure determination of the small ubiquitin-related modifier SUMO-1[J]. J Mol Biol, 1998, 280(2): 275.
  • 7Butt T R, Edavettal S C, Hall J P, et al. SUMO fusion technology for difficult-to-express proteins[J]. Protein Expr Purif, 2005, 43(1) :1.
  • 8Zuo X, Mattern M R, Tan R, etal. Expression and purification of SARS coronavirus proteins using SUMO - fusions[J]. Protein Expr Purif, 2005, 42(1) :100.
  • 9Vitt U A, Hsu S Y, Hsueh A J. Evolution and classification of cystine knot-containing hormones and related extracellular signaling molecules[J]. Mol Endocrinol, 2001, 15(5) : 681.
  • 10Sagiya Y, Yamagata H, Udaka S. Direct high level secretion into the culture medium of tuna growth hormone in biologically active form by Bacillus brevis [J]. Appl Microbiol Biotechnol, 1994,42(2- 3):358.

共引文献15

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部